Skip to main content
Premium Trial:

Request an Annual Quote

Rhinostics ELEstic/ELEbot Platform

Rhinostics, a Waltham, Massachusetts-based sample collection technology company, has launched the ELEstic swab collection device and ELEbot decapper. ELEstic includes a high-performance swab attached to a cap that screws into a 75-mm by 13-mm tube, the diagnostic industry standard that fits into most of the larger closed molecular testing platforms, Rhinostics said. The ELEbot decapper provides 24-tube automated decapping of swab samples that can be placed upstream of these molecular testing platforms for sample elution and decapping prior to transferring the sample directly into the diagnostics testing system.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.